Search results
Covid Vaccine Side Effects: 4 Takeaways From Our Investigation
New York Times· 2 days agoThousands of Americans believe they experienced rare but serious side effects. Apoorva Mandavilli...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 4 days agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
Van ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 2 days agoVan ECK Associates Corp cut its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 13.7% in the fourth quarter, according to the company in its most recent disclosure ...
Why Earnings Season Could Be Great for BioNTech (BNTX)
Zacks via Yahoo Finance· 2 days agoInvestors are always looking for stocks that are poised to beat at earnings season and BioNTech SE...
BioNTech (BNTX) to Release Earnings on Monday
ETF DAILY NEWS· 6 days agoBioNTech (NASDAQ:BNTX – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Monday, May 6th. Analysts expect BioNTech ...
Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR | JD Supra
JD Supra· 5 days agoWe previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, “Moderna”) against BioNTech SE, BioNTech...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 2 days agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 3 days agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and...
Earnings will drive the market next week — what we expect from 2 portfolio stocks
CNBC· 13 hours agoWithout any major economic reports, earnings — especially forward guidance and management commentary...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 days agoAfter hitting a two-year high in February, biotech stocks sloughed off in April and have started to...
